Meanwhile, the Gen Zers who actively invest are often associated with meme stocks, cryptocurrencies, and other speculative plays instead of blue-chip stocks. Those volatile investments might generate some stunning short-term gains, but it's undeniably tough to maintain that momentum over the long term.

The Fed pivoting back to a hawkish stance is the biggest risk facing the market right now, HSBC said.

Stocks could be heading into a more volatile stretch during October, following unusually large gains for September, according to David Laut, chief investment officer of California-based Kerux Financial.

Some research suggests that the overwhelming majority of day traders not only fail to beat the market, but actually lose money over the long run. Axsome Therapeutics is a mid-cap biotech company that currently has three products on the market: depression medicine Auvelity,

It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector,

Defense is big business in 2025. But US contractors aren’t leading the way when it comes to stock market performance. European contractors are the ones playing offense. Read more

Stocks opened higher Monday, shaking off fears of a possible midweek government shutdown as enthusiasm returned for artificial-intelligence shares. The Dow Jones Industrial Average rose 104 points, or 0.

Investors who buy these high-yield stocks now can look forward to steadily rising dividend payments in the years to come.

Five high-quality companies pay monthly dividends, which seems ideal for passive income-oriented investors seeking upside appreciation.